It is a healthcare private limited company based in Nagpur, Maharashtra, India, established in 2011.
2011 | Nagpur, Maharashtra, India | ActiveCentral India Institute Of Haematology And Oncology Private Limited, a active private limited company, was established on 12 May 2011 in Nagpur, Maharashtra, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U85100MH2011PTC217386. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 21 professional, Its leadership includes Surekha Avinash Pophali (Director), Avinash Keshaorao Pophali (Director). Past directors included Prateek Pophali, Prachi Avinash Pophali, Priyanka Avinash Pophali. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 169, Abhyankar Nagar, Nagpur, Maharashtra, 440010.
U85100MH2011PTC217386
217386
12 May 2011
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Central India Institute Of Haematology And Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surekha Avinash Pophali | Director | 12 May 2011 | Current |
| Avinash Keshaorao Pophali | Director | 12 May 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 21 Dec 2022 | Past |
| Pramod Abcsdd | Director | 21 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Central India Institute Of Haematology And Oncology Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.48% decrease. The company also saw a substantial fall in profitability, with a 38.8% decrease in profit. The company's net worth moved up by a moderate rise of 5.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Central India Institute Of Haematology And Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Central India Institute Of Haematology And Oncology has a workforce of 21 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Central India Institute Of Haematology And Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Central India Institute Of Haematology And Oncology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Central India Institute Of Haematology And Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Central India Institute Of Haematology And Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Surekha Avinash Pophali was appointed as a Director was appointed as a Director on 12 May 2011 & has been associated with this company since 14 years 6 months . was documented.
Progress on Avinash Keshaorao Pophali was appointed as a Director was appointed as a Director on 12 May 2011 & has been associated with this company since 14 years 6 months . was documented.
Progress on Central India Institute Of Haematology And Oncology Private Limited was registered on 12 May 2011 with Roc Mumbai & aged 14 years 6 months as per MCA records. was documented.
The CIN of Central India Institute Of Haematology And Oncology Private Limited is U85100MH2011PTC217386.
Central India Institute Of Haematology And Oncology Private Limited is headquartered at 169, Abhyankar Nagar, Nagpur, Maharashtra, 440010.
Central India Institute Of Haematology And Oncology Private Limited was incorporated on 12 May 2011.
The current directors of Central India Institute Of Haematology And Oncology Private Limited are
The primary industry of Central India Institute Of Haematology And Oncology Private Limited is Hospital And Medical Care.
Central India Institute Of Haematology And Oncology Private Limited is unlisted.
The authorized capital of Central India Institute Of Haematology And Oncology Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Central India Institute Of Haematology And Oncology Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX